(1R,2R,3R,5S)-2,6,6-Trimethylbicyclo[3.1.1]heptan-3-amine

Catalog No. :
ACNZPK148
CAS No. :
69460-11-3
Molecular Formula :
C10H19N
Molecular Weight :
153.27

IUPAC Name:(1R,2R,3R,5S)-2,6,6-trimethylbicyclo[3.1.1]heptan-3-amine

(1R,2R,3R,5S)-2,6,6-Trimethylbicyclo[3.1.1]heptan-3-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$118.00Login to see priceIn stockInquiry
250mg97%$198.00Login to see priceIn stockInquiry
1g97%$492.00Login to see priceIn stockInquiry
5g97%$983.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1R,2R,3R,5S)-2,6,6-Trimethylbicyclo[3.1.1]heptan-3-amine
IUPAC Name(1R,2R,3R,5S)-2,6,6-trimethylbicyclo[3.1.1]heptan-3-amine
MDL No.MFCD00192238
Molecular FormulaC10H19N
Molecular Weight153.27
SMILESN[C@@H]1C[C@]2([H])C[C@@]([C@H]1C)([H])C2(C)C
InChI KeyVPTSZLVPZCTAHZ-BZNPZCIMSA-N
Synonym(1R,2R,3R,5S)-(-)-Isopinocampheylamine, 95% | Bicyclo[3.1.1]heptan-3-amine, 2,6,6-trimethyl-, (1R,2R,3R,5S)- | (1R,2R,3R,5S)-2,6,6-trimethyl-bicyclo[3.1.1]hept-3-ylamine | SCHEMBL1538066 | (-)-isopinocampheyl amine | LSR-2-007D | (-)-Isopinocampheylamine
CAS No.69460-11-3
PubChem CID11744832

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACNZPK148 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNZPK148 route product structure diagram
    ACNZPK14869460-11-3 In Stock
Inquiry

2. ACNZPK148 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNZPK148 route product structure diagram
    ACNZPK14869460-11-3 In Stock
Inquiry

Comments (0)